Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cedazo-Minguez

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Internal Medicine|April 22, 2014
Pathways to Alzheimer's diseaseJ Hardy, N Bogdanovic, B Winblad, et al.
Journal of Neuroscience Research|October 13, 2001
Caspase cleavage of exon 9 deleted presenilin-1 is an early event in apoptosis induced by calcium ionophore A 23187 in SH-SY5Y neuroblastoma cellsB O Popescu, A Cedazo-Minguez, L M Popescu, et al.
Neurochemistry International|September 11, 1999
Nicergoline stimulates protein kinase C mediated alpha-secretase processing of the amyloid precursor protein in cultured human neuroblastoma SH-SY5Y cellsA Cedazo-Minguez, L Bonecchi, B Winblad, et al.
Cell Death and Differentiation|November 29, 2005
Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's diseaseS Akterin, R F Cowburn, A Miranda-Vizuete, et al.
Biochemical Society Symposium|July 13, 2001
Apolipoprotein E and beta A4-amyloid: signals and effectsT G Ohm, U Hamker, A Cedazo-Minguez, et al.
Oncogene|December 17, 2009
Ezrin mediates c-Myc actions in prostate cancer cell invasionY-C Chuan, D Iglesias-Gato, L Fernandez-Perez, et al.
International Journal of Sports Medicine|October 21, 2014
Resistance training does not have an effect on cognition or related serum biomarkers in nonagenarians: a randomized controlled trialJ R Ruiz, F Gil-Bea, N Bustamante-Ara, et al.
Neuroscience Letters|January 28, 2012
Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanismsA Besga, A Cedazo-Minguez, I Kåreholt, et al.
Journal of Internal Medicine|July 10, 2019
Current and emerging avenues for Alzheimer's disease drug targetsR Loera-Valencia, A Cedazo-Minguez, P A Kenigsberg, et al.
Journal of Internal Medicine|March 16, 2017
Can LDL cholesterol be too low? Possible risks of extremely low levelsA G Olsson, B Angelin, G Assmann, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Internal Medicine|April 22, 2014
Pathways to Alzheimer's diseaseJ Hardy, N Bogdanovic, B Winblad, et al.
Journal of Neuroscience Research|October 13, 2001
Caspase cleavage of exon 9 deleted presenilin-1 is an early event in apoptosis induced by calcium ionophore A 23187 in SH-SY5Y neuroblastoma cellsB O Popescu, A Cedazo-Minguez, L M Popescu, et al.
Neurochemistry International|September 11, 1999
Nicergoline stimulates protein kinase C mediated alpha-secretase processing of the amyloid precursor protein in cultured human neuroblastoma SH-SY5Y cellsA Cedazo-Minguez, L Bonecchi, B Winblad, et al.
Cell Death and Differentiation|November 29, 2005
Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's diseaseS Akterin, R F Cowburn, A Miranda-Vizuete, et al.
Biochemical Society Symposium|July 13, 2001
Apolipoprotein E and beta A4-amyloid: signals and effectsT G Ohm, U Hamker, A Cedazo-Minguez, et al.
Oncogene|December 17, 2009
Ezrin mediates c-Myc actions in prostate cancer cell invasionY-C Chuan, D Iglesias-Gato, L Fernandez-Perez, et al.
International Journal of Sports Medicine|October 21, 2014
Resistance training does not have an effect on cognition or related serum biomarkers in nonagenarians: a randomized controlled trialJ R Ruiz, F Gil-Bea, N Bustamante-Ara, et al.
Neuroscience Letters|January 28, 2012
Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanismsA Besga, A Cedazo-Minguez, I Kåreholt, et al.
Journal of Internal Medicine|July 10, 2019
Current and emerging avenues for Alzheimer's disease drug targetsR Loera-Valencia, A Cedazo-Minguez, P A Kenigsberg, et al.
Journal of Internal Medicine|March 16, 2017
Can LDL cholesterol be too low? Possible risks of extremely low levelsA G Olsson, B Angelin, G Assmann, et al.
Pageof 1